Skip to Content


Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH)

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

Notice of Cancellation/Correction: CDC published a notice in the Federal Register on December 27, 2013, Volume 78, Number 249, Pages 78964-78965, to announce a February 6, 2014, Audio Conference Call of the ABRWH-SDRR. This meeting was canceled due to a lack of quorum for the meeting. Notice will be provided when the meeting is rescheduled, in accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463). CDC published a cancellation notice in the Federal Register on February 14, 2014, Volume 79, Number 31, Pages 8970-8971, that incorrectly identified the ABRWH-SDRR committee as the “Board of Scientific Counselors, Office of Infectious Diseases (BSC, OID)”.

Contact Person for More Information: Theodore Katz, Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road NE., Mailstop E-20, Atlanta Georgia 30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, Email

This notice is published less than the required 15 days prior to the start of the announced meeting, in accordance with Section 102-3.150(b) of the GSA Final Rule (2001) that allows for exceptions to the meeting notification time requirement. Section 102-3.150(b) states the following: “In exceptional circumstances, the agency or an independent Presidential advisory committee may give less than 15 calendar days” notice, provided that the reasons for doing so are included in the advisory committee meeting notice published in the Federal Register.”

In this case, the agency is giving less than 15 days' notice due to the inability to have quorum for the meeting.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Start Signature

Catherine Ramadei,

Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2014-04086 Filed 2-25-14; 8:45 am]